Affiliation:
1. Department of Chemical and Pharmaceutical Sciences, University of Trieste, Piazzale Europa 1, 34127 Trieste, Italy
Abstract
This review discusses the entire progress made on the anthelmintic drug praziquantel, focusing on the solid state and, therefore, on anhydrous crystalline polymorphs, amorphous forms, and multicomponent systems (i.e., hydrates, solvates, and cocrystals). Despite having been extensively studied over the last 50 years, new polymorphs and the greater part of their cocrystals have only been identified in the past decade. Progress in crystal engineering science (e.g., the use of mechanochemistry as a solid form screening tool and more strategic structure-based methods), along with the development of analytical techniques, including Synchrotron X-ray analyses, spectroscopy, and microscopy, have furthered the identification of unknown crystal structures of the drug. Also, computational modeling has significantly contributed to the prediction and design of new cocrystals by considering structural conformations and interactions energy. Whilst the insights on praziquantel polymorphs discussed in the present review will give a significant contribution to controlling their formation during manufacturing and drug formulation, the detailed multicomponent forms will help in designing and implementing future praziquantel-based functional materials. The latter will hopefully overcome praziquantel’s numerous drawbacks and exploit its potential in the field of neglected tropical diseases.
Reference132 articles.
1. (2023, November 20). Schistosomiasis. Available online: https://www.who.int/news-room/fact-sheets/detail/schistosomiasis.
2. Praziquantel–50 Years of Research;Waechtler;ChemMedChem,2023
3. SIMET (2023). Quaderni della Società Italiana di Medicina Tropicale e Salute Globale (SIMET) n°7, SIMET.
4. Schistosomiasis;McManus;Nat. Rev. Dis. Primers,2018
5. Human Schistosomiasis;Colley;Lancet,2014